CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 1 of 1
Non-Antibody Products
Page 1,077 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| RS 17053 (hydrochloride) | An α1A-AR antagonist; selectively binds to the α1A-AR (Ki = 2.… | 5 mg | 33548-5 | More Info |
| RS 25344 (hydrochloride) | A PDE4 inhibitor (IC50 = 0.3 nM); selective for PDE4 over PDE1, -2, and -3… | 10 mg | 37793-10 | More Info |
| RS 25344 (hydrochloride) | A PDE4 inhibitor (IC50 = 0.3 nM); selective for PDE4 over PDE1, -2, and -3… | 100 mg | 37793-100 | More Info |
| RS 25344 (hydrochloride) | A PDE4 inhibitor (IC50 = 0.3 nM); selective for PDE4 over PDE1, -2, and -3… | 25 mg | 37793-25 | More Info |
| RS 25344 (hydrochloride) | A PDE4 inhibitor (IC50 = 0.3 nM); selective for PDE4 over PDE1, -2, and -3… | 50 mg | 37793-50 | More Info |
| (1R,3S)-3-Hydroxycyclopentane acetic acid | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11383-50 | More Info |
| (1R,3S)-3-Hydroxycyclopentane acetic acid methyl ester | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11387-50 | More Info |
| (1R,3S)-3-Hydroxycyclopentane carboxylic acid benzyl ester | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11370-50 | More Info |
| (1R,3S)-3-Hydroxycyclopentane carboxylic acid methyl ester | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11374-50 | More Info |
| (R,S)-hydroxy Ramelteon Metabolite M-II | A mixed isomer preparation of ramelteon metabolite M-II; has an (R,S) conf… | 1 mg | 33897-1 | More Info |
| (R,S)-hydroxy Ramelteon Metabolite M-II | A mixed isomer preparation of ramelteon metabolite M-II; has an (R,S) conf… | 10 mg | 33897-10 | More Info |
| (R,S)-hydroxy Ramelteon Metabolite M-II | A mixed isomer preparation of ramelteon metabolite M-II; has an (R,S) conf… | 5 mg | 33897-5 | More Info |
| (R)-SLV 319 | (R)-SLV 319 is the inactive enantiomer of SLV 319 with 100-fold less affin… | 1 mg | 10009227-1 | More Info |
| (R)-SLV 319 | (R)-SLV 319 is the inactive enantiomer of SLV 319 with 100-fold less affin… | 10 mg | 10009227-10 | More Info |
| (R)-SLV 319 | (R)-SLV 319 is the inactive enantiomer of SLV 319 with 100-fold less affin… | 5 mg | 10009227-5 | More Info |
| RSM-932A | A selective inhibitor of CHOKα (IC50s = 1 and >50 µM for CHOK&… | 1 mg | 21518-1 | More Info |
| RSM-932A | A selective inhibitor of CHOKα (IC50s = 1 and >50 µM for CHOK&… | 10 mg | 21518-10 | More Info |
| RSM-932A | A selective inhibitor of CHOKα (IC50s = 1 and >50 µM for CHOK&… | 5 mg | 21518-5 | More Info |
| (6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic Acid | An intermediate in the biosynthesis of thymidylate | 1 mg | 31333-1 | More Info |
| (6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic Acid | An intermediate in the biosynthesis of thymidylate | 10 mg | 31333-10 | More Info |
| (6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic Acid | An intermediate in the biosynthesis of thymidylate | 5 mg | 31333-5 | More Info |
| (2R,3S)-N-Cbz-6-oxo-2,3-Diphenylmorpholine | A chiral building block; has been used in the stereoselective synthesis of… | 1 g | 30497-1 | More Info |
| (2R,3S)-N-Cbz-6-oxo-2,3-Diphenylmorpholine | A chiral building block; has been used in the stereoselective synthesis of… | 250 mg | 30497-250 | More Info |
| (2R,3S)-N-Cbz-6-oxo-2,3-Diphenylmorpholine | A chiral building block; has been used in the stereoselective synthesis of… | 500 mg | 30497-500 | More Info |
| (R,S)-N-Nitrosoanatabine | A tobacco-specific nitrosamine; not carcinogenic in rats at 1, 3, and 9 mm… | 1 mg | 33851-1 | More Info |
| (R,S)-N-Nitrosoanatabine | A tobacco-specific nitrosamine; not carcinogenic in rats at 1, 3, and 9 mm… | 5 mg | 33851-5 | More Info |
| R788 (sodium salt) | A prodrug of R406, an inhibitor of Syk (Ki = 30 nM); produces anti-inflamm… | 1 mg | 18501-1 | More Info |
| R788 (sodium salt) | A prodrug of R406, an inhibitor of Syk (Ki = 30 nM); produces anti-inflamm… | 10 mg | 18501-10 | More Info |
| R788 (sodium salt) | A prodrug of R406, an inhibitor of Syk (Ki = 30 nM); produces anti-inflamm… | 5 mg | 18501-5 | More Info |
| RS Repeat Peptide (trifluoroacetate salt) | A peptide substrate for Clk1; has been used to identify inhibitors of Clk1… | 1 mg | 37498-1 | More Info |
| RS Repeat Peptide (trifluoroacetate salt) | A peptide substrate for Clk1; has been used to identify inhibitors of Clk1… | 10 mg | 37498-10 | More Info |
| RS Repeat Peptide (trifluoroacetate salt) | A peptide substrate for Clk1; has been used to identify inhibitors of Clk1… | 25 mg | 37498-25 | More Info |
| RS Repeat Peptide (trifluoroacetate salt) | A peptide substrate for Clk1; has been used to identify inhibitors of Clk1… | 5 mg | 37498-5 | More Info |
| (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride) | A reduced form of folic acid that serves as a cofactor in methyltransferas… | 1 mg | 20526-1 | More Info |
| (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride) | A reduced form of folic acid that serves as a cofactor in methyltransferas… | 10 mg | 20526-10 | More Info |
| (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride) | A reduced form of folic acid that serves as a cofactor in methyltransferas… | 25 mg | 20526-25 | More Info |
| (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride) | A reduced form of folic acid that serves as a cofactor in methyltransferas… | 5 mg | 20526-5 | More Info |
| RS 09 (trifluoroacetate salt) | A TLR4 agonist; activates NF-κB in a concentration-dependent manner… | 1 mg | 33152-1 | More Info |
| RS 09 (trifluoroacetate salt) | A TLR4 agonist; activates NF-κB in a concentration-dependent manner… | 10 mg | 33152-10 | More Info |
| RS 09 (trifluoroacetate salt) | A TLR4 agonist; activates NF-κB in a concentration-dependent manner… | 5 mg | 33152-5 | More Info |
| RS 09 (trifluoroacetate salt) | A TLR4 agonist; activates NF-κB in a concentration-dependent manner… | 500 µg | 33152-500 | More Info |
| RSV-604 | An inhibitor of RSV; binds to RSV nucleoprotein (Kd = 1.31 µM); redu… | 1 mg | 29041-1 | More Info |
| RSV-604 | An inhibitor of RSV; binds to RSV nucleoprotein (Kd = 1.31 µM); redu… | 10 mg | 29041-10 | More Info |
| RSV-604 | An inhibitor of RSV; binds to RSV nucleoprotein (Kd = 1.31 µM); redu… | 25 mg | 29041-25 | More Info |
| RSV-604 | An inhibitor of RSV; binds to RSV nucleoprotein (Kd = 1.31 µM); redu… | 5 mg | 29041-5 | More Info |
| RSV F Protein Extracellular Domain (Strain RSS-2) | Source: Recombinant C-terminal His-tagged RSV F protein extracellular doma… | 100 µg | 37020-100 | More Info |
| RTA 408 | Binds Keap1 and attenuates the degradation of Nrf2 at concentrations ≤2… | 1 mg | 17854-1 | More Info |
| RTA 408 | Binds Keap1 and attenuates the degradation of Nrf2 at concentrations ≤2… | 10 mg | 17854-10 | More Info |
| RTA 408 | Binds Keap1 and attenuates the degradation of Nrf2 at concentrations ≤2… | 25 mg | 17854-25 | More Info |
| RTA 408 | Binds Keap1 and attenuates the degradation of Nrf2 at concentrations ≤2… | 5 mg | 17854-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile